Jason Siegel1,2, Michael A Pizzi3,4, J Brent Peel3, David Alejos4,5, Nnenne Mbabuike6, Benjamin L Brown6, David Hodge7, W David Freeman3,4,6. 1. Department of Neurology, Mayo Clinic, 4500 San Pablo Road,, Jacksonville, FL, 32224, USA. Siegel.jason@mayo.edu. 2. Department of Critical Care Medicine, Mayo Clinic, Jacksonville, FL, USA. Siegel.jason@mayo.edu. 3. Department of Neurology, Mayo Clinic, 4500 San Pablo Road,, Jacksonville, FL, 32224, USA. 4. Department of Critical Care Medicine, Mayo Clinic, Jacksonville, FL, USA. 5. Research Trainee Program, Mayo Clinic, Jacksonville, FL, USA. 6. Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, USA. 7. Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA.
Abstract
PURPOSE OF REVIEW: This review will highlight the recent advancements in acute ischemic stroke diagnosis and treatment, with special attention to new features and recommendations of stroke care in the neurocritical care unit. RECENT FINDINGS: New studies suggest that pre-hospital treatment of stroke with mobile stroke units and telestroke technology may lead to earlier stroke therapy with intravenous tissue plasminogen activator (tPA), and recent studies show tPA can be given in previously contraindicated situations. More rapid automated CT perfusion and angiography may demonstrate a vascular penumbra for neuroendovascular intervention. Further, the greatest advance in acute stroke treatment since 2014 is the demonstration that neuroendovascular catheter-based thrombectomy with stent retrievers recanalizing intracranial large vessel occlusion (LVO) improves both recanalization and long-term outcomes in several trials. Hemorrhagic transformation and severe large infarct cerebral edema remain serious post-stroke challenges, with new guidelines describing who and when patients should get medical or surgical intervention. The adage "time is brain" directs the most evidence-based approach for rapid stroke diagnosis for tPA eligible and LVO recanalization using an orchestrated team approach. The neurocritical care unit is the appropriate location to optimize stroke outcomes for the most severely affected stroke patients.
PURPOSE OF REVIEW: This review will highlight the recent advancements in acute ischemic stroke diagnosis and treatment, with special attention to new features and recommendations of stroke care in the neurocritical care unit. RECENT FINDINGS: New studies suggest that pre-hospital treatment of stroke with mobile stroke units and telestroke technology may lead to earlier stroke therapy with intravenous tissue plasminogen activator (tPA), and recent studies show tPA can be given in previously contraindicated situations. More rapid automated CT perfusion and angiography may demonstrate a vascular penumbra for neuroendovascular intervention. Further, the greatest advance in acute stroke treatment since 2014 is the demonstration that neuroendovascular catheter-based thrombectomy with stent retrievers recanalizing intracranial large vessel occlusion (LVO) improves both recanalization and long-term outcomes in several trials. Hemorrhagic transformation and severe large infarct cerebral edema remain serious post-stroke challenges, with new guidelines describing who and when patients should get medical or surgical intervention. The adage "time is brain" directs the most evidence-based approach for rapid stroke diagnosis for tPA eligible and LVO recanalization using an orchestrated team approach. The neurocritical care unit is the appropriate location to optimize stroke outcomes for the most severely affected strokepatients.
Authors: Andrew Bivard; Christopher Levi; Longting Lin; Xin Cheng; Richard Aviv; Neil J Spratt; Min Lou; Tim Kleinig; Billy O'Brien; Kenneth Butcher; Jingfen Zhang; Jim Jannes; Qiang Dong; Mark Parsons Journal: Stroke Date: 2017-01-19 Impact factor: 7.914
Authors: Mayank Goyal; Bijoy K Menon; Wim H van Zwam; Diederik W J Dippel; Peter J Mitchell; Andrew M Demchuk; Antoni Dávalos; Charles B L M Majoie; Aad van der Lugt; Maria A de Miquel; Geoffrey A Donnan; Yvo B W E M Roos; Alain Bonafe; Reza Jahan; Hans-Christoph Diener; Lucie A van den Berg; Elad I Levy; Olvert A Berkhemer; Vitor M Pereira; Jeremy Rempel; Mònica Millán; Stephen M Davis; Daniel Roy; John Thornton; Luis San Román; Marc Ribó; Debbie Beumer; Bruce Stouch; Scott Brown; Bruce C V Campbell; Robert J van Oostenbrugge; Jeffrey L Saver; Michael D Hill; Tudor G Jovin Journal: Lancet Date: 2016-02-18 Impact factor: 79.321
Authors: S E Kasner; A M Demchuk; J Berrouschot; E Schmutzhard; L Harms; P Verro; J A Chalela; R Abbur; H McGrade; I Christou; D W Krieger Journal: Stroke Date: 2001-09 Impact factor: 7.914
Authors: Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton Journal: Lancet Date: 2004-03-06 Impact factor: 79.321
Authors: G W J Harston; N Rane; G Shaya; S Thandeswaran; M Cellerini; F Sheerin; J Kennedy Journal: AJNR Am J Neuroradiol Date: 2015-01-29 Impact factor: 3.825
Authors: Andrew Bivard; Christopher Levi; Venkatesh Krishnamurthy; Patrick McElduff; Ferdi Miteff; Neil J Spratt; Grant Bateman; Geoffrey Donnan; Stephen Davis; Mark Parsons Journal: Brain Date: 2015-03-25 Impact factor: 13.501
Authors: Christos D Strubakos; Michelle Malik; Joseph M Wider; Icksoo Lee; Christian A Reynolds; Panayiotis Mitsias; Karin Przyklenk; Maik Hüttemann; Thomas H Sanderson Journal: J Cereb Blood Flow Metab Date: 2019-05-21 Impact factor: 6.200